Riyadh Hospital Launches First Type 1 Diabetes Therapy

King Faisal Specialist Hospital and Research Centre in Riyadh has introduced Saudi Arabia's first preventive therapy designed to slow the progression of stage 2 type 1 diabetes, marking a notable step for the Kingdom's healthcare sector.

The treatment is available to adults and children aged 8 years or older who meet the approved medical protocol. In its initial application, the therapy was used with two eligible patients assessed at the hospital.

The therapy aims to delay the onset of clinical symptoms and slow the move toward stage 3 type 1 diabetes, potentially giving eligible patients more time before the condition advances. This preventive approach differs from traditional treatments that focus on managing the disease after symptoms appear.

What patients should know

Access to the treatment currently requires a specialist medical assessment through King Faisal Specialist Hospital and Research Centre. Public information does not confirm whether self-referral is possible or whether online booking is required.

Several details remain undisclosed at this stage, including the drug name, treatment duration, cost in Saudi Riyal, eligibility-testing and appointment fees, insurance coverage, and validity periods. There is also no confirmed application process through any government digital platform for this hospital treatment.

For families and residents living with type 1 diabetes, the availability of a preventive option locally is a significant development. Those who believe they or a family member may qualify are advised to seek a specialist medical evaluation to determine eligibility.

---

Stay updated with the latest news, events, sports updates, business insights, real estate and lifestyle stories on Saudi Living — the leading online platform for residents, expats, and visitors in Saudi Arabia.

Follow Saudi Living for daily updates:

• Instagram - @saudiliving
• X - @saudiliving
• Facebook - @saudiliving
• YouTube - @saudiliving